 |
|
|
Gideon and Sevgi Rodan IBMS Fellowship 2007
Applications close: 16 April 2007
Throughout their productive careers, Gideon Rodan, M.D., Ph.D. and
his wife and frequent collaborator Sevgi Rodan, Ph.D. have made outstanding
contributions to the field of bone biology, including: the isolation
and
characterization of the first transformed osteoblastic cell line (ROS
17/2.8), the unraveling of the PTH signal transduction mechanisms,
the development
of the concept of osteoblast-osteoclast interaction, the identification
and characterization of integrin antagonists as osteoclast inhibitors,
the development of the blockbuster drug Alendronate (Fosamax), and the
cloning of alkaline phosphatase.
Both scientists worked for many years
in the Department of Bone Biology and Osteoporosis Research at Merck & Company,
and both have been leaders in several bone-related organizations. Gideon
served as President of the International Bone and Mineral Society from
2001 to 2003.
The Rodans have served as role models and mentors for hundreds
of young scientists in the bone field, and IBMS is pleased recognize
their many contributions through The Gideon and Sevgi Rodan IBMS Fellowship.
Purpose:
The Rodans’ Fellowship will be given annually to support the salary
of a deserving young investigator in the bone field. Support will be
$US40,000 for one year, not renewable, payable to the successful applicant’s
institution. No overhead may be paid from the fellowship. The research
may be basic, translational, clinical, or outcomes-based in bone biology
or diseases of the bone.
Eligibility:
- The fellowship must be held in an academic institution—for
example, a medical school, hospital, or research institute;
- Both Applicant
and the Head of the recipient laboratory must be members of IBMS;
- Applicant must be a Fellow within three years of completing either
a doctoral
degree (M.D., Ph.D., D.D.S.) or must have carried out equivalent
research in basic or clinical bone biology for up to six years since
their first
degree (M.B.B.S, B.D.Sc, B.Vet Sc etc);
- A high standard of research
achievement for this career stage, with publications and presentations.
Review:
In accessing the application, the following will be taken into account:
- The number and quality of research projects
completed or currently engaged in, and the extent of the applicant’s
personal contribution to such research;
- Evidence of innovation or leadership in the
applicant’s
research career to the present time;
- Evidence in the application of
particular novelty or initiative on the part of the applicant. For
example preference
may be given to an applicant who is either moving to a new laboratory
or proposing a period of research in another laboratory, either to
achieve progress in a specific project or to learn a technique;
- Success
in competitive
scholarship or fellowship applications and in competitive peer-reviewed
grant applications;
- Evidence of communication skills in oral presentations.
Application Format:
Applications may be submitted by email, fax or sent to IBMS Headquarters
directly. Applicants should submit a description of the research proposal
on which the award would be spent, and the benefits to be obtained
from the year’s independent postdoctoral salary. This should
be no more than four pages, excluding references. The candidate’s
curriculum vitae must be also included, as well as a supporting letter
from a mentor.
 Fellowship
Information and Application form (PDF: 91KB)
Deadline:
Application deadline for 2007 Fellowship: 16 April 2007
Rating Process:
Submissions will be reviewed by the IBMS Awards Committee and
rated according to the record of the candidate academically and according
to the above criteria, as well as to the scientific value of the proposed
project. Up to two (applicant – nominated) referees may be consulted.
The final decision will be made by the IBMS Executive Committee.
Award and Funding Process:
The Award will be presented at the 17th Scientific Meeting of
the IBMS, June 27, 2007, Montreal, Canada.
Meeting
website: www.ibms2007.com
Funding is made possible through the generous support of Merck & Co.,
Inc.
Previous Recipients:
See the IBMS
website for a list of previous recipients of this fellowship.
|
|
